DBI was founded as a spin-off of USZ/UKBB and ETH in 2018 with the vision to uncover the full potential of Molecular Breath Analysis to advance precision medicine and make it available for general health care. The core competences are in patterned analytical analysis of data with highest accuracy.

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Key business